Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-3 of our report dated March 29, 2022 relating to the financial statements of Monte Rosa Therapeutics, Inc., appearing in the Annual Report on Form 10-K of Monte Rosa Therapeutics, Inc., for the year ended December 31, 2021. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
July 1, 2022